McDonald’s tests high-protein menu as users of weight-loss drug GLP-1 increase
McDonald’s Corporation (NYSE:MCD) is adapting its menu as a growing number of Americans taking GLP-1 weight-loss drugs, such as Ozempic and Wegovy, modify portion sizes, snacking habits and beverage choices. During an earnings conference call on Wednesday, CEO Chris Kempczinski He said McDonald’s is testing menu items to appeal to customers who take GLP-1 medications….